A San Francisco startup called Preventive, founded by gene-editing scientist Lucas Harrington, has raised $30 million to research embryo editing technology aimed at preventing hereditary diseases before birth.

UNILAD

The Wall Street Journal

A San Francisco startup called Preventive, founded by gene-editing scientist Lucas Harrington, has raised $30 million to research embryo editing technology aimed at preventing hereditary diseases before birth.

OpenAI CEO Sam Altman and Coinbase CEO Brian Armstrong are among the early investors backing Preventive, with Altman's husband Oliver Mulherin stating he led their investment to help families "avoid disease." The broader industry has received funding from Peter Thiel, Alexis Ohanian and Anne Wojcicki.

Metro

OpenAI CEO Sam Altman and Coinbase CEO Brian Armstrong are among the early investors backing Preventive, with Altman's husband Oliver Mulherin stating he led their investment to help families "avoid disease." The broader industry has received funding from Peter Thiel, Alexis Ohanian and Anne Wojcicki.

Federal law prohibits the U.S. Food and Drug Administration (FDA) from reviewing applications for human trials involving genetically edited embryos intended for pregnancy, forcing companies to explore operations outside the country.

Moneycontrol

Federal law prohibits the U.S. Food and Drug Administration (FDA) from reviewing applications for human trials involving genetically edited embryos intended for pregnancy, forcing companies to explore operations outside the country.

As the practice is banned in over 70 countries, Preventive has looked to those where embryo editing might be permitted, including the UAE. While Preventive and another startup called Orchid Focus on disease prevention, companies like Herasight and Nucleus Genomics say they're focused on other genetic traits, including intelligence and height.

illuminem

As the practice is banned in over 70 countries, Preventive has looked to those where embryo editing might be permitted, including the UAE. While Preventive and another startup called Orchid Focus on disease prevention, companies like Herasight and Nucleus Genomics say they're focused on other genetic traits, including intelligence and height.

Other startups, including only known instance of genetically edited babies occurred in 2018 when Chinese scientist He Jiankui created twins altered to resist HIV, resulting in his three-year prison sentence for illegal medical practices.

Other startups, including only known instance of genetically edited babies occurred in 2018 when Chinese scientist He Jiankui created twins altered to resist HIV, resulting in his three-year prison sentence for illegal medical practices.

Critics, including University of California, Berkeley's Fyodor Urnov, warn that commercial embryo editing risks crossing into eugenics, while supporters argue the technology could help families with devastating genetic disorders like cystic fibrosis.

New York Post

Critics, including University of California, Berkeley's Fyodor Urnov, warn that commercial embryo editing risks crossing into eugenics, while supporters argue the technology could help families with devastating genetic disorders like cystic fibrosis.

A San Francisco startup called Preventive, founded by gene-editing scientist Lucas Harrington, has raised $30 million to research embryo editing technology aimed at preventing hereditary diseases before birth.</span

The Wall Street Journal #

UNILAD #

OpenAI CEO Sam Altman and Coinbase CEO Brian Armstrong are among the early investors backing Preventive, with Altman's husband Oliver Mulherin stating he led their investment to help families avoid genetic illness.</span

Metro #

OpenAI CEO Sam Altman and Coinbase CEO Brian Armstrong are among the early investors backing Preventive, with Altman's husband Oliver Mulherin stating he led their investment to help families avoid genetic illness.

Federal law prohibits the Food and Drug Administration from reviewing applications for human trials involving genetically edited embryos intended for pregnancy, forcing companies to explore operations outside the United States.</span

Moneycontrol #

Federal law prohibits the Food and Drug Administration from reviewing applications for human trials involving genetically edited embryos intended for pregnancy, forcing companies to explore operations outside the United States.

Preventive has investigated foreign jurisdictions including the United Arab Emirates where embryo editing might be permitted, as the practice is illegal in the US and banned in over 70 countries worldwide.</span

illuminem #

Preventive has investigated foreign jurisdictions including the United Arab Emirates where embryo editing might be permitted, as the practice is illegal in the US and banned in over 70 countries worldwide.

The only known instance of genetically edited babies occurred in 2018 when Chinese scientist He Jiankui created twins altered to resist HIV, resulting in his three-year prison sentence for illegal medical practices.</span

The only known instance of genetically edited babies occurred in 2018 when Chinese scientist He Jiankui created twins altered to resist HIV, resulting in his three-year prison sentence for illegal medical practices.

Critics including UC Berkeley's Fyodor Urnov warn that commercial embryo editing risks crossing into eugenics, while supporters argue the technology could help families with devastating genetic disorders like cystic fibrosis.</span

New York Post #4317

Critics including UC Berkeley's Fyodor Urnov warn that commercial embryo editing risks crossing into eugenics, while supporters argue the technology could help families with devastating genetic disorders like cystic fibrosis.

SF Startup Raises $30M for Embryo Gene Editing Research

SF Startup Raises $30M for Embryo Gene Editing Research

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

SF Startup Raises $30M for Embryo Gene Editing Research

SF Startup Raises $30M for Embryo Gene Editing Research

Sign Up for Our Free NewslettersSign Up for Our Free Newsletters

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters